| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 1. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | etoricoxib (Arcoxia®) |
| Formulation | 30 mg, 60 mg, 90 mg and 120 mg film-coated tablet |
| Reference number | 139 |
| Indication | Symptomatic relief of osteoarthritis, rheumatoid arthritis and the pain and signs of inflammation associated with acute gouty arthritis |
| Company | Merck Sharp & Dohme Ltd |
| BNF chapter | Musculoskeletal & joint diseases |
| Submission type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 23/01/2008 |